Decreased Expression of NPRL2 in Renal Cancer Cells is Associated with Unfavourable Pathological, Proliferation and Apoptotic Features
- 194 Downloads
The tumor suppressor gene nitrogen permease regulator-like 2(NPRL2) NPRL2 expressed obviously in many normal human tissues, but reduced in expression in many human tumors significantly. In this study, we detected the expression of NPRL2 in 78 clear cell renal cell carcinoma (ccRCC) by immunohistochemistry and correlated it with clinicopathological parameters. Meanwhile, the function of NPRL2 in human ccRCC was further explored after transfected recombinant expressing plasmids pEGFP-N1-NPRL2 into human renal cancer 786-0 cells. NPRL2 protein showed high expression in 67 of 78 cases of adjacent normal tissues (85.9 %), which was significantly higher than that in ccRCC tissues (23/78, 29.5 %). Clinic pathological analysis showed that NPRL2 expression was significantly correlated with histological grade (P = 0.044), TNM stage (P = 0.025) and lymph node metastasis (P = 0.028). MTT assay demonstrated that NPRL2 could obviously inhibit renal cancer cell proliferation. Flow cytometric analysis revealed that NPRL2 could induce renal cancer cells apoptosis and arrest the cell cycle in G0/G1 phase. In conclusion, NPRL2 is closely correlated to unfavourable pathological, proliferation and apoptotic features in ccRCC.
KeywordsNPRL2 Renal cancer carcinoma Transfection Proliferation Apoptosis
Conflict of interest
The authors declare that they have no conflict of interest.
- 2.Campbell SC, Novick AC (2002) Renal tumors. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ (eds) Kavoussi LR, Novick AC, Partin AW, Peters CA (ed.), Campbell’s urology. Elsevier, Philadelphia, pp 2672–2686Google Scholar
- 8.Lerman MI, Minna JD (2000) The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 60(21):6116–6133PubMedGoogle Scholar
- 10.Sasatomi E, Finkelstein SD, Woods JD et al (2002) Comparison of accumulated allele loss between primary tumor and lymph node metastasis in stage II non-small cell lung carcinoma: implications for the timing of lymph node metastasis and prognostic value. Cancer Res 62(9):2681–2689PubMedGoogle Scholar
- 21.Edge SB, Byrd DR, Compton CC et al (2009) AJCC cancer staging manual, 7th edn. Springer Verlag, New YorkGoogle Scholar
- 22.Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) (2004) World Health Organization classification of tumors. Pathology and genetics of tumors of the urinary system and male genital organs. IARC Press, Lyon, pp 16–18Google Scholar
- 25.Gao Y, Wang J, Fan G (2012–2013) NPRL2 is an independent prognostic factor of osteosarcoma. Cancer Biomark 12(1):31–36Google Scholar